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Abstract
Background: Red blood cell transfusions are critical in burn management. The subsequent iron overload that can
occur from this treatment can lead to secondary hemochromatosis with multi-organ damage.
Case Presentation: While well recognized in patients receiving chronic transfusions, we present a case outlining
the acute development of hemochromatosis secondary to multiple transfusions in a burn patient.
Conclusions: Simple screening laboratory measures and treatment options exist which may significantly reduce
morbidity; thus, we believe awareness of secondary hemochromatosis in those treating burn patients is critical.
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Background
Acute and chronic treatment of the severely burned indi-
vidual is often complex due to many physical and psycho-
logical factors [1, 2]. Resuscitation involving packed red
blood cell (RBC) transfusion is often essential [3]. How-
ever, RBC transfusion carries potential risks including
hemolytic reactions and infections, as well as other com-
plications that are often overlooked such as iron overload
[4, 5]. Each unit of RBCs contains 200–250 mg of iron,
and with no physiologic excretion mechanism, multiple
transfusions can result in iron overload [6]. Iron overload
is not benign and can result in the development of life
threatening chronic disease processes.
While iron overload can be caused by RBC transfu-
sions, there is a wide differential for this abnormality
that can be divided based on heritability. The hereditary
category includes hemochromatosis gene (HFE) and
non-HFE-related genetic defects both leading to an
abnormality of increased absorption of dietary iron.
Non-hereditary causes of iron overload include repeat
RBC transfusions to treat chronic anemia in diseases
such as thalassemia major, chronic hemolytic anemia
and others, chronic liver disease, iatrogenic administration
of parental iron or RBC transfusions, neonatal iron over-
load, aceruloplasminemia, and African iron overload [6, 7].
Hemochromatosis is a disease characterized by iron
accumulation in tissues. Initial symptoms and signs in-
clude skin pigmentation, fatigue, erectile dysfunction,
and arthralgia while later stages of the disease result in
cardiomyopathy, diabetes mellitus, hypogonadism, hypo-
pituitarism, and hypoparathyroidism, as well as liver fi-
brosis and cirrhosis which can lead to hepatocellular
carcinoma [6]. As iron overload is the initial step to devel-
oping hemochromatosis, the differential diagnosis for such
is the same as we have described for iron overload. Here,
we present the first reported case in the literature, to the
best of our knowledge, of secondary hemochromatosis
from parenteral iron overload due to multiple RBC trans-
fusions in a burn patient.
Case presentation
A previously healthy 19-year-old male was transferred to
hospital with extensive deep burns covering approxi-
mately 85 % total body surface area (TBSA). After initial
assessment and debridement in the operating room, he
was brought to the general systems intensive care unit
(ICU) for acute renal failure likely due to myoglobuli-
nuria. He remained in the ICU for 34 days until he was
transferred to the burn unit. Several operations includ-
ing multiple debridements and allograft applications
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were performed throughout his time in the ICU and
burn unit. During his extended stay, he was treated for
many complications, including multiple infections, pancrea-
titis, deep vein thrombosis, pleural effusion, cardiomyop-
athy, chronic diarrhea, depression, as well as upper airway
and upper gastrointestinal tract bleeding secondary to ul-
cers. As well, he developed another acute kidney injury
thought to be secondary to acute tubular necrosis and had
multiple instances of elevated liver enzymes and abnormal
liver function tests. Both of these organ insults were
thought to be secondary to medications administered, as
these values corrected with discontinuation of these insult-
ing agents. In total, his acute care admission lasted approxi-
mately 15 months with 33 operations/procedures needed
before he could be transferred to a rehabilitation unit.
Throughout his prolonged stay, he was worked up for
anemia as he required massive amounts of RBC transfu-
sions to maintain an average hemoglobin value over his
admission of 95 g/L. This value fluctuated regularly fall-
ing into the low 70s on many occasions necessitating the
use of blood products. Multiple gastrointestinal bleeds
presenting with melena were thought to be large con-
tributors to this laboratory abnormality. The question of
hemolysis was raised as early on in his treatment course;
he occasionally had elevated lactate dehydrogenase and
bilirubin values, as well as positive direct antiglobulin
tests. However, his haptoglobin never fell below the nor-
mal range and multiple peripheral blood smears had
minimal morphological evidence of hemolysis. His
chronic anemia was managed with multiple RBC trans-
fusions throughout his hospital admission.
While in hospital, he had multiple zinc, selenium, and
copper serum values in the low and normal ranges.
However, he was noted to have elevated serum iron
levels and an increased iron saturation index reaching
94 % (normal <60 %). His iron indices were followed
throughout his stay as all values progressed to outside
the normal limits (Table 1). Subsequent magnetic reson-
ance imaging (MRI) of the abdomen verified the diagno-
sis of hemochromatosis by showing iron deposition in
the liver and spleen (Fig. 1). A search for etiology re-
vealed that in just less than 15 months, he had received
292 units of packed RBCs. He did not receive any ex-
ogenous administration of iron during his treatment
course. With this information, it was thought that the
increased iron saturation was due to a transfusional iron
overload. Given his ethnicity and age in the presence of a
clear alternative diagnosis, the clinical decision to forego
genetic testing was made by the Internal Medicine and
Hematology services. He had not manifested any typical
signs or symptoms of secondary hemochromatosis. The
Hematology service was consulted, and as per protocol,
he was started on twice weekly phlebotomies [7]. Due to
pre-syncopal episodes, he was unable to tolerate this, and
thus, phlebotomy was performed weekly.
Discussion
There is a wide differential of potential causes to con-
sider in patients presenting with iron overload. In this
case, the MRI suggested a pattern of iron overload con-
sistent with a secondary (i.e., non-hereditary) process. A
review of secondary causes reveals that he did not
receive parenteral iron during his stay, did not have a
history of chronic anemia or liver disease prior, is not of
African descent, and did not have any neurological dys-
function to suggest aceruloplasminemia. Based upon the
Table 1 Iron values
Date Iron (μmol/L) Total iron binding
capacity (μmol/L)
Saturation index (%) Ferritin (μg/L)
July 28/2012 (admission) – – – –
August 2/2012 5 25 20 73
October 30/2012 5 10 50 1883
May 8/2013 4 24 17 >1500
October 19/2013 23 30 77 1425
February 6/2014 11 68 16
April 30/2014 46 49 94 >1650
May 7/2014 32 47 68
May 14/2014 38 <41 >93 >1650
May 21/2014 34 <37 >92 >1650
May 23/2014 31 34 91 >1650
May 28/2014 30 34 88 >1650
June 4/2014 35 <38 >92 >1650
June 20/2014 (discharge) – – – –
Normal values: serum iron (8–25 μmol/L), total iron binding capacity (40–80 μmol/L), saturation index (16–60 %), ferritin (12–300 μg/L)
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quantity of RBC transfusions administered during his
course, it appears this is the most likely diagnosis.
This is the first reported case of transfusional iron over-
load resulting in secondary hemochromatosis in a burn
patient. Previously, this phenomenon has been shown to
occur in patients receiving chronic transfusions over an
extended period of time for treatment of blood disorders
[8, 9]. This evidence is in keeping with the notion that sec-
ondary hemochromatosis due to transfusions is mainly a
concern in chronically transfused patients. It has been
suggested that signs of iron overload could be present
with as few as 10–20 transfusions [10]. This case substan-
tiates that multiple acute transfusions may also lead to
secondary hemochromatosis.
Based upon this report, a screening protocol for sec-
ondary hemochromatosis may be useful in burn patients
receiving acute transfusions, as has been suggested in
the population receiving chronic transfusions; however,
the details of such a protocol require further study [9].
Screening for secondary hemochromatosis requires
straightforward measurement of serum iron indices,
and treatment includes iron chelation and/or serial
phlebotomy. There is a technique for phlebotomy de-
scribed in the hereditary hemochromatosis population
that could possibly be applied to transfusionally over-
loaded patients. The suggested regiment includes
removing one unit of blood once to twice a week as
serum ferritin analysis is performed periodically to
ensure its decline [7]. Given the simplicity of screening
and availability of treatment options, which reduce long-
term morbidity, further research in this area is essential to
document the prevalence of secondary hemochromatosis
in the burn population and the potential need for such a
screening protocol.
Conclusions
Burn patients treated with RBC transfusions are at risk
of iron overload and secondary hemochromatosis.
Awareness of this treatable condition can reduce long-
term morbidity. Further investigation is required to de-
fine screening protocols.
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